Our Valuable Team Members
Presently, ECBio’s team consists of highly specialized personnel in areas as broad as animal cell technology, biotechnology, cell biology and molecular genetics.
Helder Cruz has a 5-year degree in Applied Chemistry, branch of Biotechnology, from Faculty of Sciences and Technology – New University of Lisbon (1994), an MBA in International Businesses from Catholic University – Lisbon (1999), a PhD in Biotechnology-Biochemical Engineering from ITQB-UNL (1999) and a Post-doc in the GLP-Good Laboratory Practices Lab of IBET (2000). He has large scientific experience obtained from participating in several international research projects in recombinant protein therapeutics (at the Animal Cell Technology Lab from IBET that included periods abroad at GBF (now HZI)-Germany and MIT-USA) and in Biosensors (at the Biomolecular Diagnostics Lab from ITQB/IBET). Helder has also experience as an evaluator and reviewer of EC-funded projects, as consultant of national and international companies and as lecturer of Cell Biology, Biochemistry and Bioengineering. Helder is founder and the current CEO of ECBio.
Pedro Cruz has a 5-year degree in Chemical Engineering, branch of Biotechnology from IST – University of Lisbon (1994), an MBA in International Businesses from the Catholic University – Lisbon (1999), and a PhD in Biochemical Engineering from ITQB – UNL (1999). Pedro was involved in the start-up of iBET’s pilot plant and worked as a researcher at Novartis-Switzerland. Has large scientific experience gained through the participation in several international research projects in the fields of viral vaccines and gene therapy as a Senior Researcher at the Animal Cell Technology Lab of iBET, including various periods abroad (Innogenetics-Belgium, GBF (now HZI)–Germany, Penn State U.–USA). He is also lecturing on bachelor and masters management courses at Universidade Atlântica – Oeiras, in the areas of entrepreneurship, strategy and project valuation. Pedro is founder and the current CSO of ECBio.